Supplementary Figure S7 from PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical Models
Abstract
FGFR2 controls HER3 to induce p85β binding and signaling in FGFR2 high-expressing cell lines
Fields of Study & Subjects
Fibroblast Growth Factor Research
Sympathectomy and Hyperhidrosis Treatments
Eosinophilic Disorders and Syndromes
Publication details
- Publication date
- 6 January 2026